IVI develops affordable vaccines
By J.R. Breen
Contributing Writer
The headquarters of the International Vaccine Institute (IVI), a rare case of an organization with a global mission based in Korea, lies on the slopes of Mt. Gwanak in southern Seoul.
The institute focuses on diseases effecting developing world populations, specifically children and has already developed a number of vaccines.
``These vaccines are of essentially no commercial interest to the pharmaceutical companies, because the people who tend to get these diseases are the poorest of the poor,'' says Director General John D. Clemens. ``That is really one of our niches, to develop vaccines where there is a so-called market failure.''
Since its establishment in 1996, and the opening of its laboratories only four years ago, IVI has created the world's first affordable vaccine for cholera, licensed in India, and is working on numerous others.
``Cholera is not a democratic disease,'' Clemens said. ``It selectively preys upon the very poor. Countries could provide a vaccine to the poor if it were in the range of 1 dollar per dose, and t
May 18, 2010